These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

530 related articles for article (PubMed ID: 30326281)

  • 1. Improving diagnosis and case management of patients with tuberculosis: A review of gaps, needs and potential solutions in accessing laboratory diagnostics.
    Andama A; Somoskovi A; Mandel B; Bell D; Gutierrez C
    Infect Genet Evol; 2019 Aug; 72():131-140. PubMed ID: 30326281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cursed duet today: Tuberculosis and HIV-coinfection.
    Tiberi S; Carvalho AC; Sulis G; Vaghela D; Rendon A; Mello FC; Rahman A; Matin N; Zumla A; Pontali E
    Presse Med; 2017 Mar; 46(2 Pt 2):e23-e39. PubMed ID: 28256380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tuberculosis: a new vision for the 21st century.
    Small PM
    Kekkaku; 2009 Nov; 84(11):721-6. PubMed ID: 19999594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The tuberculosis epidemic. Scientific challenges and opportunities.
    Ginsberg AM
    Public Health Rep; 1998; 113(2):128-36. PubMed ID: 9719813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tuberculosis control in crisis-causes and solutions.
    Kaplan G
    Prog Biophys Mol Biol; 2020 May; 152():6-9. PubMed ID: 31626823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug-resistant tuberculosis in the European Union: opportunities and challenges for control.
    Fears R; Kaufmann S; Ter Meulen V; Zumla A;
    Tuberculosis (Edinb); 2010 May; 90(3):182-7. PubMed ID: 20382566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Achieving STOP TB Partnership goals: perspectives on development of new diagnostics, drugs and vaccines for tuberculosis.
    Mwaba P; McNerney R; Grobusch MP; O'Grady J; Bates M; Kapata N; Maeurer M; Zumla A
    Trop Med Int Health; 2011 Jul; 16(7):819-27. PubMed ID: 21489070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New diagnostic tools for tuberculosis.
    Perkins MD
    Int J Tuberc Lung Dis; 2000 Dec; 4(12 Suppl 2):S182-8. PubMed ID: 11144551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New diagnostics for latent and active tuberculosis: state of the art and future prospects.
    Pai M; O'Brien R
    Semin Respir Crit Care Med; 2008 Oct; 29(5):560-8. PubMed ID: 18810689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical management of adults and children with multidrug-resistant and extensively drug-resistant tuberculosis.
    Dheda K; Chang KC; Guglielmetti L; Furin J; Schaaf HS; Chesov D; Esmail A; Lange C
    Clin Microbiol Infect; 2017 Mar; 23(3):131-140. PubMed ID: 27756712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The re-emergence of tuberculosis.
    Porter JD; McAdam KP
    Annu Rev Public Health; 1994; 15():303-23. PubMed ID: 8054087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Review on emergence of drug-resistant tuberculosis (MDR & XDR-TB) and its molecular diagnosis in Ethiopia.
    Saravanan M; Niguse S; Abdulkader M; Tsegay E; Hailekiros H; Gebrekidan A; Araya T; Pugazhendhi A
    Microb Pathog; 2018 Apr; 117():237-242. PubMed ID: 29486274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pediatric tuberculosis: new guidelines and recommendations.
    Perez-Velez CM
    Curr Opin Pediatr; 2012 Jun; 24(3):319-28. PubMed ID: 22568943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isoniazid-resistant tuberculosis: a cause for concern?
    Stagg HR; Lipman MC; McHugh TD; Jenkins HE
    Int J Tuberc Lung Dis; 2017 Feb; 21(2):129-139. PubMed ID: 28234075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Local staff making sense of their tuberculosis data: key to quality care and ending tuberculosis.
    Heldal E; Dlodlo RA; Mlilo N; Nyathi BB; Zishiri C; Ncube RT; Siziba N; Sandy C
    Int J Tuberc Lung Dis; 2019 May; 23(5):612-618. PubMed ID: 31097071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experience establishing tuberculosis laboratory capacity in a developing country setting.
    Paramasivan CN; Lee E; Kao K; Mareka M; Kubendiran G; Kumar TA; Keshavjee S; Satti H; Alabi G; Raviglione M; Roscigno G
    Int J Tuberc Lung Dis; 2010 Jan; 14(1):59-64. PubMed ID: 20003696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Using Patient Pathway Analysis to Design Patient-centered Referral Networks for Diagnosis and Treatment of Tuberculosis: The Case of the Philippines.
    Garfin C; Mantala M; Yadav R; Hanson CL; Osberg M; Hymoff A; Makayova J
    J Infect Dis; 2017 Nov; 216(suppl_7):S740-S747. PubMed ID: 29117352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New and improved diagnostics for detection of drug-resistant pulmonary tuberculosis.
    O'Grady J; Maeurer M; Mwaba P; Kapata N; Bates M; Hoelscher M; Zumla A
    Curr Opin Pulm Med; 2011 May; 17(3):134-41. PubMed ID: 21415753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trends and challenges of multi-drug resistance in childhood tuberculosis.
    Zhuang Z; Sun L; Song X; Zhu H; Li L; Zhou X; Mi K
    Front Cell Infect Microbiol; 2023; 13():1183590. PubMed ID: 37333849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.